title: [Idiopathic pulmonary fibrosis: recent diagnostic and therapeutic advances].
abstract: Idiopathic pulmonary fibrosis (IPF) is the most frequent of the idiopathic interstitial pneumonias. It is a progressive disorderwith a poor prognosis. Its diagnosis requires the careful exclusion of potential causes, and a pattern of usual interstitial pneumonia at high-resolution computed tomography or video-assisted surgical lung biopsy. Several recent randomized trials have profoundly modified the therapeutic management of IPF. The combination of prednisone and azathioprine, often prescribed until recently, has been shown to be harmful and is no longer indicated. N-acetylcystein, also used in the past decade, failed to show an efficacy. However, two new antifibrotic drugs, pirfenidone and nintedanib, have for the first time proven effective in slowing disease progression.
authors.affiliation: CHUV, Lausanne. nicolas.petitpierre@gmail.com
authors.forename: N
authors.initials: N
authors.lastname: Petitpierre
authors.forename: C
authors.initials: C
authors.lastname: Beigelman
authors.forename: I
authors.initials: I
authors.lastname: Letovanec
authors.forename: L P
authors.initials: LP
authors.lastname: Nicod
authors.forename: R
authors.initials: R
authors.lastname: Lazor
mesh_terms: D001379:Azathioprine / Q000627:therapeutic use; D003948:Diagnostic Techniques, Respiratory System / Q000639:trends; D006801:Humans; D054990:Idiopathic Pulmonary Fibrosis / Q000145:classification / Q000175:diagnosis* / Q000453:epidemiology / Q000628:therapy*; D011241:Prednisone / Q000627:therapeutic use; D020775:Thoracic Surgery, Video-Assisted; D014057:Tomography, X-Ray Computed
chemical_list: D001379:Azathioprine; D011241:Prednisone